EUROPEAN JOURNAL OF

PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

ICV - 79.57

Abstract

OUTCOMES OF IMMUNOTHERAPY BY INTRAVESICAL BCG VACCINE INSTILLATION ON TUMOR RECURRENCE OF NON-MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER

Maher Hmedan*, Hassan Naser and Mohammad Kanaan

ABSTRACT

Background: In 1976 Morales et al were the first to prove the effectiveness of intravesical BCG on the bladder cancer and reported a remarkable decrease in the rates of recurrence of superficial bladder cancer. In 1990, BCG was approved by the Food and Drug Administration (FDA) as a primary treatment for the bladder carcinoma in situ (CIS) and as a preventive treatment for papillary tumors, thus BCG became essential in complementary treatment for NMIBC. Objective: This study aims to evaluate the effectiveness of the immunotherapy by intravesical BCG vaccine instillation in reducing recurrence rates in non-muscle-invasive urothelial bladder cancer patients
(NMIBC). Methods and materials: Patients diagnosed with bladder transitional cell carcinoma by transurethral resection with no muscular invasion in pathology and who had a high or intermediate risk for tumor recurrence were included. BCG immunotherapy Onco TICE (CFU=2-8×108) was given as an induction course of 6 weekly instillations. Maintenance treatment 3 weekly instillations every 3 months for 1 year, was given as a single standard. The follow-up program included a cystoscopy every 3 months with biopsies from the site of the previous curettage or new recurrence. Results: Our study reported recurrence in 26 (43.7%) cases. Tumors ≥3 cm and T1 tumors were more common (73.1%) and (80.8%) in the recurrence group respectively, however there was no important significance (p>0.05). On the other hand: high grade tumors, multifocal tumors, tumors with previous recurrence and tumors without concomitant CIS, each was more common in the recurrence group with an important significance(p<0.05) (88.5%,76.9%,92.3% and80.8%)respectively. Conclusion: We support the previous studys that intravesical BCG vaccine instillation reduces the recurrence rates in non-muscle-invasive urothelial bladder cancer ptients(NMIBC), especially when a maintenance treatment program is used. This study also supports the recommendation of using BCG as the frst-line supportive treatment in patients with high-risk NMIBC.

Keywords: Non-muscle-invasive bladder cancer, BCG, Recurrence.


[Full Text Article] [Download Certificate]

EJMPR Citation Report

  All Since 2021
 Citation  4339  2797
 h-index  23  20
 i10-index  109  52

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2026 issue has been successfully launched on 1 NOVEMBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

BEST ARTICLE AWARDS

European Journal of Pharmaceutical and Medical Research is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Prof. Dr. Dhrubo Jyoti Sen
Download Article : Click Here

Google Scholar

Indian Science Publications

InfoBase Index (In Process)

SOCOLAR, China

Research Bible, Fuchu, Tokyo. JAPAN

International Society for Research activity (ISRA)

Scientific Indexing Services (SIS)

Polish Scholarly Bibliography

Global Impact Factor (GIF) (Under Process)

Universal Impact Factor

International Scientific Indexing (ISI), UAE

Index Copernicus

CAS (A Division of American Chemical Society) USA (Under Process)

Directory of Open Access Journal (DOAJ, Sweden, in process)

UDLedge Science Citation Index

CiteFactor

Directory Of Research Journal Indexing (DRJI)

Indian citation Index (ICI)

Journal Index (JI, Under Process)

Directory of abstract indexing for Journals (DAIJ)

Open Access Journals (Under Process)

Impact Factor Services For International Journals (IFSIJ)

Cosmos Impact Factor

Jour Informatics (Under Process)

Eurasian Scientific Journal Index (ESJI)

International Innovative Journal Impact Factor (IIJIF)

Science Library Index, Dubai, United Arab Emirates

Pubmed Database [NLM ID: 101669306] (Under Process)

IP Indexing (IP Value 2.40)

Web of Science Group (Under Process)

Directory of Research Journals Indexing

Scholar Article Journal Index (SAJI)

International Scientific Indexing ( ISI )

Scope Database

Academia

Doi-Digital Online Identifier

ISSN National Centre

Zenodo Indexing

International CODEN Service, USA